Silexion Therapeutics Corp Ordinary Shares (SLXN) Stock Price, Quote & AI Analysis

Live SLXN stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Silexion Therapeutics Corp Ordinary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Silexion Therapeutics Corp Ordinary Shares (SLXN), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

SLXN
Silexion Therapeutics Corp Ordinary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
4.640000
High
5.040000
Low
4.495000
Volume
102,020
VWAP
-
Market Cap
$6,378,349.68
52W Range
$2.31 - $223.60
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Silexion Therapeutics Corp Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Silexion Therapeutics Corp Ordinary Shares Overview

Company information

Company Overview

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.

Company Details
Market Cap
$2.11M
Shares Outstanding
418,995
Weighted Shares Outstanding
3,126,642
CEO
Ilan Hadar
Address
12 ABBA HILLEL ROAD, RAMAT GAN, L3, 5250606
Employees
14
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Silexion Therapeutics Corp Ordinary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...